EmailFacebookXLinkedIn

Monthly Archives: November 2015

Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis

2021-07-29T22:38:07+02:00

van Ravesteyn NT, Stout NK, Schechter CB, Heijnsdijk EA, Alagoz O, Trentham-Dietz A, Mandelblatt JS, de Koning HJ.  J Natl Cancer Inst. 2015 May 6;107(7). pii: djv103. doi: 10.1093/jnci/djv103. Print 2015 Jul. (Pubmed)

Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis2021-07-29T22:38:07+02:00

Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer

2021-07-29T22:38:07+02:00

Jiang DM, Raissouni S, Mercer J, Kumar A, Goodwin R, Heng DY, Tang PA, Doll C, MacLean A, Powell E, Price-Hiller J, Monzon J, Cheung WY, Vickers MM. Ann Oncol. 2015 Oct;26(10):2102-6. doi: 10.1093/annonc/mdv331. Epub 2015 Jul 30. (Pubmed)

Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer2021-07-29T22:38:07+02:00

Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group

2021-07-29T22:38:07+02:00

Goede V, Bahlo J, Chataline V, Eichhorst B, Dürig J, Stilgenbauer S, Kolb G, Honecker F, Wedding U, Hallek M.  Leuk Lymphoma. 2015 Oct 13:1-8. [Epub ahead of print] (Pubmed)

Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group2021-07-29T22:38:07+02:00

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

2021-07-29T22:38:07+02:00

Dombret H, Seymour JF, Butrym A, Wierzbowska A, Selleslag D, Jang JH, Kumar R, Cavenagh J, Schuh AC, Candoni A, Récher C, Sandhu I, Bernal del Castillo T, Al-Ali HK, Martinelli G, Falantes J, Noppeney R, Stone RM, Minden MD, McIntyre H, Songer S, Lucy LM, Beach CL, Döhner H.  Blood. 2015 Jul 16;126(3):291-9. doi: 10.1182/blood-2015-01-621664. Epub 2015 May 18. (Blood Journal)

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts2021-07-29T22:38:07+02:00

Stay in touch and share our news!

SIOG Head Office

  • International Society of Geriatric Oncology
    P/A Comptabilis
    9 route des Jeunes
    1227 Les Acacias - Switzerland

  • +49 30 24603-152
  • enquiry@siog.org

ECOSOC Special

In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).

Quick links

 

Stay in the loop with SIOG’s newsletter!

Subscribe now

Powered by K.I.T. Group – Crafted for Excellence

Go to Top